GuidelinesOther guideline
Sensory Organs
ATC Code S01LA04 Medicine Ranibizumab Indication Sub-retinal neovascular membranes and non resolving macular odema NEMLC Recommendation Not Approved Bevacizumab to be agent for this indication Review Indicators None Date Ratified 10 December 2015 National Essential Medicines List Committee (NEMLC) Tertiary and Quaternary Level Essential Medicines List November 2023
| ATC Code | S01LA04 |
| Medicine | Ranibizumab |
| Indication | Sub-retinal neovascular membranes and non resolving macular odema |
| NEMLC Recommendation | Not Approved Bevacizumab to be agent for this indication |
| Review Indicators | None |
| Date Ratified | 10 December 2015 |
National Essential Medicines List Committee (NEMLC)
Tertiary and Quaternary Level Essential Medicines List
November 2023